| KEGG pathway | wnt signaling pathway, HSA04310; endometrial cancer, HSA05213; small cell lung cancer, HSA05222; thyroid cancer, HSA05216; acute myeloid leukemia, HSA05221; colorectal cancer, HSA05210; chronic myeloid leukemia, HSA05220; jak stat signaling pathway, HSA04630; erbb signaling pathway, HSA04012; bladder cancer, HSA05219; mapk signaling pathway, HSA04010; tgf beta signaling pathway, HSA04350 |
|---|
| NCI pathway | IL2 signaling events mediated by STAT5, il2_stat5pathway; IL6-mediated signaling events, il6_7pathway; Validated targets of C-MYC transcriptional activation, myc_activpathway; Regulation of nuclear beta catenin signaling and target gene transcription, betacatenin_nuc_pathway; Presenilin action in Notch and Wnt signaling, ps1pathway; PDGFR-beta signaling pathway, pdgfrbpathway; IL2 signaling events mediated by PI3K, il2_pi3kpathway; Ceramide signaling pathway, ceramide_pathway; E2F transcription factor network, e2f_pathway; AP-1 transcription factor network, ap1_pathway; C-MYB transcription factor network, cmyb_pathway; Notch signaling pathway, notch_pathway; FOXM1 transcription factor network, foxm1pathway; p73 transcription factor network, p73pathway; Regulation of nuclear SMAD2/3 signaling, smad2_3nuclearpathway; IL2-mediated signaling events, il2_1pathway; CD40/CD40L signaling, cd40_pathway; LKB1 signaling events, lkb1_pathway; Regulation of Telomerase, telomerasepathway; C-MYC pathway, myc_pathway; Validated nuclear estrogen receptor alpha network, era_genomic_pathway; Validated targets of C-MYC transcriptional repression, myc_represspathway |
|---|
| WIKI pathway | Wnt Signaling Pathway Netpath(Homo sapiens), WP363; miRNAs involved in DNA damage response(Homo sapiens), WP1545; Integrated Breast Cancer Pathway(Homo sapiens), WP1984; TP53 Network(Homo sapiens), WP1742; IL-2 Signaling Pathway(Homo sapiens), WP49; Spinal Cord Injury(Mus musculus), WP2432; TSLP Signaling Pathway(Homo sapiens), WP2203; Wnt Signaling Pathway(Mus musculus), WP403; IL-5 Signaling Pathway(Homo sapiens), WP127; ErbB Signaling Pathway(Homo sapiens), WP673; p38 MAPK Signaling Pathway(Mus musculus), WP350; Spinal Cord Injury(Homo sapiens), WP2431; Aryl Hydrocarbon Receptor(Homo sapiens), WP2586; Integrated Pancreatic Cancer Pathway(Homo sapiens), WP2377; ESC Pluripotency Pathways(Mus musculus), WP339; B Cell Receptor Signaling Pathway(Homo sapiens), WP23; MAPK Signaling Pathway(Homo sapiens), WP382; DNA Damage Response (only ATM dependent)(Homo sapiens), WP710; Wnt Signaling Pathway and Pluripotency(Mus musculus), WP723; TSH signaling pathway(Homo sapiens), WP2032; ErbB signaling pathway(Mus musculus), WP1261; Apoptosis(Homo sapiens), WP254; Apoptosis(Mus musculus), WP1254; G1 to S cell cycle control(Homo sapiens), WP45; MAPK signaling pathway(Mus musculus), WP493; Gastric cancer network 2(Homo sapiens), WP2363; RB in Cancer(Homo sapiens), WP2446; G1 to S cell cycle control(Mus musculus), WP413; Neural Crest Differentiation(Homo sapiens), WP2064; Metastatic brain tumor(Homo sapiens), WP2249; Notch Signaling Pathway(Homo sapiens), WP268+http://wikipathways.org/instance/WP61; DNA Damage Response(Homo sapiens), WP707; EGFR1 Signaling Pathway(Mus musculus), WP572; IL-7 Signaling Pathway(Homo sapiens), WP205; Hair Follicle Development: Induction (Part 1 of 3)(Homo sapiens), WP2804; miRNA Regulation of DNA Damage Response(Homo sapiens), WP1530; p38 MAPK Signaling Pathway(Homo sapiens), WP400; Wnt Signaling Pathway and Pluripotency(Homo sapiens), WP399; PluriNetWork(Mus musculus), WP1763; Wnt Signaling Pathway(Homo sapiens), WP428 |
|---|